Abstract

Two recent surveys of genetic engmeering scientists have assessed how scientists in the United States and in Europe view the influence of regulation and public attention on recombinant DNA research. Generally, European researchers are more negative about this issue: they feel that public attention has hampered progress in the field more than it has helped it. The probable cause for this difference is that European countries tend to have more—and more stringent—regulations on bioengineering than the United States, although there are also national differences in the climate for bioengineering research. On the other hand, scientists in the United States seem extremely concerned about competitiveness, especially relative to Japan.